Table 2 Baseline characteristics of two NHR groups of patients with STEMI

Age (y)

65 (57–74)

57 (50–65)

Male/female (n)

298/97

126/11

SBP on admission (mmHg)

125 (108–144)

119 (102–141)

DBP on admission (mmHg)

74 (66–86)

72 (64–89)

Smoking (n, %)

259 (65.6%)

110 (80.3%)

Hypertension (n, %)

214 (54.2%)

62 (45.3%)

Diabetes (n, %)

125 (31.6%)

45 (32.8%)

MYO (ng/ml)

500.0 (170.0–500.0)

500.0 (359.0–500.0)

CK-MB (µg/L)

22.9(3.4–61.2)

36.8 (7.5–68.8)

cTn I (ng/ml)

2.51 (0.19–15.90)

5.55 (0.56–17.24)

WBC (×10⁹/L)

9.77 (8.37–11.60)

14.11 (12.29–17.05)

RBC (×10¹²/L)

4.49 (4.09–4.83)

4.64 (4.31–5.13)

Hemoglobin (g/l)

136 (125–147)

143 (131–159)

platelet count (×10⁹/L)

183 (148–228)

210 (174–255)

Neutrophil count (×10⁹/L)

8.12 (6.67–9.74)

12.32(10.46–14.62)

Lymphocyte count (×10⁹/L)

1.09 (0.75–1.54)

1.34 (0.87–1.71)

Monocyte count (×10⁹/L)

0.39 (0.29–0.53)

0.51 (0.39–0.72)

ALT (U/L)

38 (28–55)

50 (38–73)

AST (U/L)

90 (44–210)

156 (68–292)

Urea nitrogen (mmol/L)

5.8 (4.8–7.0)

5.6 (4.8–6.7)

Creatinine (µmol/L)

71 (61–85)

76 (66–93)

UA (µmol/L)

342 (283–402)

372 (302–438)

TC (mmol/L)

4.48 (3.81–5.22)

4.22 (3.50–4.79)

TG (mmol/L)

1.42 (0.94–2.12)

1.86 (1.30–2.88)

LDL-c (mmol/L)

2.90 (2.29–3.59)

2.77 (2.13–3.24)

HDL-c (mmol/L)

1.18 (1.02–1.38)

0.86 (0.74–0.99)

hs-CRP (mg/L)

5.19 (2.00–11.29)

5.20 (2.75–11.99)

FPG (mmol/L)

6.7 (5.8–8.3)

7.3 (6.1–8.7)

HbA1c (%)

6.0 (5.7–6.7)

6.2 (5.8–7.0)

Gensini score

73 (39–90)

76 (43–90)

Killip III-IV (%)

43 (10.9%)

27 (19.9%)

LVEF (%)

56 (52–60)

57 (52–60)

MACE (n, %)

38 (9.6%)

34 (24.8%)